This exclusive report provides an in-depth look at the global Flexible Endoscopes Market. It assesses AI-enhanced lesion-detection diagnostics, the trend towards single-use disposables, and various regional insights. Essential components include competitive benchmarking, market dynamics and evaluations of advanced CMOS imaging and robotic-assisted surgical lifecycles. The global Flexible Endoscopes Market size was valued at US$ 11.17 Billion in 2025 and is poised to grow from US$ 12.03 Billion in 2026 to 20.48 Billion by 2033, growing at a CAGR of 6.30% in the forecast period (2026-2033). The report encompasses a comprehensive study period from 2020 through 2033, with detailed historical analysis and forward-looking projections across five major geographic regions. Market concentration remains at a medium level, with leading manufacturers competing on technology innovation, regulatory compliance, and clinical outcomes.
Market Size (2026)
$11.17B
Projected (2033)
$20.48B
CAGR
6.30%
Published
April 2026
Select User License
Selected
PDF Report
USD 4,900
USD 3,200
The Flexible Endoscopes Market is valued at $11.17B and is projected to grow at a CAGR of 6.30% during 2026 - 2033. North America holds the largest regional share, while Asia-Pacific (7.2%–8.4% CAGR) is the fastest-growing market.
Study Period
2020 - 2033
Market Size (2026)
$11.17B
CAGR (2026 - 2033)
6.30%
Largest Market
North America
Fastest Growing
Asia-Pacific (7.2%–8.4% CAGR)
Market Concentration
Medium
*Disclaimer: Major Players sorted in no particular order
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Global Flexible Endoscopes market valued at $11.17B in 2026, projected to reach $20.48B by 2033 at 6.30% CAGR
Key growth driver: Rising demand for minimally invasive diagnostic and therapeutic procedures (High, +2.1% CAGR impact)
North America holds the largest market share, while Asia-Pacific (7.2%–8.4% CAGR) is the fastest-growing region
AI Impact: The Flexible Endoscopes Market is changing a lot because of Artificial Intelligence. Artificial Intelligence is turning tools into new systems that can think and find problems.
11 leading companies profiled including Boston Scientific Corporation, CONMED Corporation, EndoChoice Holdings, Inc. (A subsidiary of Boston Scientific) and 8 more
The Flexible Endoscopes Market is changing a lot because of Artificial Intelligence. Artificial Intelligence is turning tools into new systems that can think and find problems. This is making a difference in how we find and look at things inside the body. We used to do this by hand. Now we have computers that can help us. These computers use something called Deep Learning Neural Networks to look at videos and find things that might be wrong like polyps or bad cells. They can even find these things better than doctors who have been doing this for a time.
By the year 2026 these smart systems will be able to check how well procedures are being done and make sure everything is working correctly. This means that doctors will be able to find problems that they might have missed before and patients will be safer. Artificial Intelligence is also being used to help with surgeries and other procedures. It is like a guide that helps doctors navigate through the body. In the year 2026 Artificial Intelligence will be used to make reports and records.
This will make it easier for doctors to keep track of what they have done and what they need to do. The Flexible Endoscopes Market is also using Artificial Intelligence to make sure that the tools they use are clean and working properly. This is all part of making the Flexible Endoscopes Market a place where we can find and fix problems in an precise way. Artificial Intelligence is helping the Flexible Endoscopes Market to become a leader, in using technology to make people healthier. The Flexible Endoscopes Market and Artificial Intelligence are working together to make this happen.
The flexible endoscopes market has firmly established itself as a key player in the world of minimally invasive medicine, transforming from basic optical instruments into advanced digital imaging systems. Right now, we're seeing a significant shift towards single-use (disposable) flexible endoscopes and high-definition video technology. This change is largely driven by the urgent need to reduce cross-contamination risks and the increasing number of diagnostic screenings in fields like gastroenterology, pulmonology and urology. One of the trends is the widespread use of Artificial Intelligence (AI) for real-time computer-aided detection (CADe) and characterization (CADx).
These innovative systems serve as a "second pair of eyes" for doctors, helping them spot subtle lesions and polyps with remarkable accuracy. The market is also moving towards outpatient and ambulatory surgical center (ASC) environments, where the portability and lower reprocessing needs of the latest flexible scopes allow for more patients to be treated efficiently. This professional setting showcases a market that has matured through clinical precision and operational effectiveness, positioning flexible endoscopy as a vital, data-driven tool for early cancer detection and complex interventional therapies.
| Year | Market Size (USD Billion) | Period |
|---|---|---|
| 2025 | $11.17B | Historical |
| 2026 | $12.05B | Forecast |
| 2027 | $13.00B | Forecast |
| 2028 | $14.02B | Forecast |
| 2029 | $15.12B | Forecast |
| 2030 | $16.32B | Forecast |
| 2031 | $17.60B | Forecast |
| 2032 | $18.99B | Forecast |
| 2033 | $20.48B | Forecast |
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Base Year: 2025The flexible endoscopes market is growing because more people want procedures that're less invasive for diagnosing and treating issues in areas like gastroenterology, pulmonology and urology.
The fact that more people have long-term diseases and need to be diagnosed also means more use of endoscopes in regular doctor visits.
One of the trends is the widespread use of Artificial Intelligence (AI) for real-time computer-aided detection (CADe) and characterization (CADx). These innovative systems serve as a "second pair of eyes" for doctors, helping them spot subtle lesions and polyps with remarkable accuracy.
The market is also moving towards outpatient and ambulatory surgical center (ASC) environments, where the portability and lower reprocessing needs of the latest flexible scopes allow for more patients to be treated efficiently.
Some challenges with endoscopes include making sure they are cleaned and disinfected properly between uses, which can be hard and take a lot of time.
Different places. Disinfect them differently and there's a risk of spreading infections, which can make doctors and nurses less confident and make their work harder.
Also it takes people to handle and maintain these devices, which adds to the work in hospitals.
There are opportunities for growth in using endoscopy for both diagnosing and treating issues. As more procedures happen in outpatient and day-care settings there's a need for endoscopes that make same-day procedures easy. With a focus on patient safety and making work easier there's room for better device designs disposable parts and simpler cleaning solutions. Using imaging and data management systems with endoscopes also makes them more useful and valuable, in the long run. 8% CAGR. Integration of cloud-based analytics and AI-driven reporting systems enhances clinical workflows and creates recurring revenue opportunities for manufacturers.
| Region | Market Share | Growth Rate |
|---|---|---|
| North America | 23.9% | 5.3%–6.8%% CAGR |
| Europe | 22.2% | 4.9%–5.2%% CAGR |
| Asia Pacific | 14.4% | 7.2%–8.4%% CAGRFastest |
| Latin America | 18.5% | 3.9%–5.5%% CAGR |
| Middle East & Africa | 21% | 4.5%–6.2%% CAGR |
Source: Claritas Intelligence — Primary & Secondary Research, 2026.
Boston Scientific Corporation CONMED Corporation EndoChoice Holdings, Inc. (A subsidiary of Boston Scientific) HOYA Corporation (PENTAX Medical) Hoya Corporation (PENTAX Medical) Stryker Corporation Medtronic plc Richard Wolf GmbH Smith & Nephew plc Arthrex, Inc. Ambu A/S B. Braun Melsungen AG. These market leaders compete through continuous innovation in imaging technology, AI integration, and disposable product development. Boston Scientific's recent WATCHMAN FLX clinical trial success demonstrates ongoing investment in advanced endoscopic solutions. CONMED's strategic exit from gastroenterology reflects portfolio optimization trends within the competitive landscape, allowing competitors to capture additional market share in high-growth segments.
MARLBOROUGH, Mass. and CHICAGO, Nov. 16, 2024 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. Key findings from the study comparing the device to first-line oral anticoagulation (OAC) including direct oral anticoagulants (DOAC) (95%) and warfarin (5%) for stroke risk reduction in patients with non-valvular atrial fibrillation following a cardiac ablation were presented in a late-breaking science session at the American Heart Association's Scientific Sessions 2024, and simultaneously published in The New England Journal of Medicine.
LARGO, Fla. (BUSINESS WIRE) Dec. 5, 2025 CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft tissue repair.
The global flexible endoscopes market was valued at USD 11.17 billion in 2025 and is expected to expand to USD 20.48 billion by 2033. This represents a steady compound annual growth rate (CAGR) of 6.30% throughout the forecast period, reflecting strong demand for advanced minimally invasive diagnostic and therapeutic procedures. See our market size analysis →
The flexible endoscopes market is growing at a CAGR of 6.30% from 2026 to 2033. This growth is primarily driven by the urgent need to reduce cross-contamination risks through single-use endoscopes and the widespread adoption of high-definition video imaging technology in clinical settings. See our growth forecast →
Single-use (disposable) flexible endoscopes and high-definition video technology segments are leading the market due to enhanced patient safety and improved diagnostic accuracy. These segments are experiencing faster adoption rates than traditional reusable endoscopes, reflecting a fundamental shift in clinical practice standards. See our segment analysis →
North America is the largest market for flexible endoscopes, driven by advanced healthcare infrastructure and high diagnostic screening adoption rates. However, Asia-Pacific is the fastest-growing region with a CAGR of 7.2–8.4%, fueled by increasing healthcare expenditures, rising diagnostic demand, and expanding minimally invasive procedure adoption. See our growth forecast → See our geography analysis →
Major market players include Boston Scientific Corporation, CONMED Corporation, EndoChoice Holdings Inc. (a Boston Scientific subsidiary), HOYA Corporation (PENTAX Medical), and Stryker Corporation. These companies lead through continuous innovation in digital imaging, AI-assisted diagnostics, and single-use endoscope technology.
Primary growth drivers are the shift toward single-use disposable endoscopes to eliminate cross-contamination risks and the widespread adoption of high-definition digital imaging and AI-powered diagnostic systems. Additionally, increasing screening procedures in gastroenterology, pulmonology, and urology departments fuel market expansion. See our key growth drivers →
Key challenges include high capital investment costs for advanced digital endoscopy systems and stringent regulatory compliance requirements. Additionally, the reprocessing and maintenance complexity of reusable endoscopes creates operational burdens that drive interest in single-use alternatives but also impact cost structures. See our market challenges →
Significant opportunities include AI-powered diagnostic automation, augmented reality visualization features, and integration of real-time pathology detection systems. Emerging markets in Asia-Pacific and Latin America present expansion opportunities due to growing healthcare infrastructure investments and increasing disease screening initiatives. See our emerging opportunities →
How this analysis was conducted
Primary Research
Secondary Research
Access detailed analysis, data tables, and strategic recommendations.